Epsilon M&A Deal Report - Merial
Transaction Multiples for the Valuation of Private Companies
Intervet/Schering-Plough Animal Health Business (now Merck Animal Health) / Merial
No EMAT :
38698
Announced Date :
09/03/2010
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Intervet/Schering-Plough Animal Health Business (now Merck Animal Health)
Target :
Merial
Country :
England
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Veterinary Pharmaceuticals
Business Description :
Merial, Sanofi-Aventis’ animal health activity , was created in 1997 as a combination of the animal health activities of Rhône-Poulenc Merieux and Merck AgVe into a joint venture in which each party...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Veterinary Pharmaceuticals » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 27/07/2011 | Zydus Animal Health (ZAHL) | Bremer Pharma | Germany | * | 38570 |
| 29/06/2011 | Private Group led by Herkules Private Equity | Hjelp24 | Norway | ** | 38520 |
Source: Epsilon Research / EMAT
